CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.

[1]  J. Ellinger,et al.  Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. , 2008, The Journal of urology.

[2]  R. Lothe,et al.  The epigenome of testicular germ cell tumors , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[3]  M. Fraga,et al.  Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN‐1) , 2006, The Journal of pathology.

[4]  Qinghua Feng,et al.  Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Köllermann,et al.  Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors , 2006, Journal of Cancer Research and Clinical Oncology.

[6]  A. Horwich,et al.  Guidelines on testicular cancer. , 2005, European urology.

[7]  B. Trock,et al.  Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy , 2005, Clinical Cancer Research.

[8]  J. Clements,et al.  Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis , 2005, British Journal of Cancer.

[9]  J. Bacik,et al.  Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors , 2004, Molecular Cancer.

[10]  A. Reeve,et al.  Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas , 2003, Genes, chromosomes & cancer.

[11]  T. Matsuda,et al.  Increasing incidence of testicular cancer worldwide: a review. , 2003, The Journal of urology.

[12]  E. Maher,et al.  Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours , 2003, Oncogene.

[13]  R. Lothe,et al.  Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer , 2002, Oncogene.

[14]  V. Reuter,et al.  Characteristic promoter hypermethylation signatures in male germ cell tumors , 2002, Molecular Cancer.

[15]  C. Plass,et al.  Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors , 2002, Oncogene.

[16]  F. O. Fackelmayer,et al.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.

[17]  L. Guillou,et al.  Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors. , 1997, The American journal of pathology.

[18]  P. Albers,et al.  Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. , 2009, The Journal of urology.

[19]  R. Fimmers,et al.  Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators , 2008, International journal of cancer.

[20]  R. Salazar,et al.  Tumor markers at the time of recurrence in patients with germ cell tumors , 2000, Cancer.